Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Alexander D MurphyCatharine PorterAnn WhiteAlys IrvingRichard AdamsRuby RayAngela CasbardReem D MahmoodSuman KaranthCong ZhouJulia PughChelsey WheelerVictoria RobertsGiorgio ArnetoliZena SalihJurjees HasanClaire MitchellRobert D MorganAndrew R ClampGordon C JaysonPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
EudraCT 2016-004618-93.